Medicare Enrolled
Dr. Napoleon Santos, D.O.
Medical Oncology · West Palm Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Santos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Santos
Dr. Napoleon Santos is a medical oncology specialist in West Palm Beach, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Santos performed 93,649 Medicare services across 2,537 unique beneficiaries.
Between the years covered by Open Payments, Dr. Santos received a total of $15,768 from 94 pharmaceutical and/or device companies across 938 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Santos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 26% volume in FL
$15,768 industry payments
Medicare Practice Summary
Medicare Utilization ↗93,649
Medicare services
Top 26% in FL for medical oncology
2,537
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,853 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 44,880 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 15,000 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 6,110 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 5,090 | $6 | $23 |
| Iron sucrose injection (Venofer) | 4,500 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 4,410 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 3,300 | $18 | $51 |
| Iron infusion (Monoferric) | 1,500 | $16 | $57 |
| Complete blood count (CBC) with differential | 1,348 | $8 | $29 |
| Blood draw (venipuncture) | 1,205 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,192 | $0 | $3 |
| Office visit, established patient (30-39 min) | 702 | $99 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 660 | $1 | $28 |
| Drug injection, under skin or into muscle | 453 | $11 | $69 |
| Office visit, established patient (20-29 min) | 442 | $68 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 432 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 282 | $102 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 251 | $50 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 206 | $23 | $84 |
| Injection, zoledronic acid, 1 mg | 176 | $7 | $69 |
| Injection of additional new drug or substance into vein | 171 | $12 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 170 | $1 | $6 |
| Administration of chemotherapy into vein, each additional hour | 114 | $23 | $79 |
| Injection of drug or substance into vein | 102 | $29 | $156 |
| Injection, diphenhydramine hcl, up to 50 mg | 91 | $1 | $3 |
| Infusion into a vein for hydration, each additional hour | 87 | $10 | $42 |
| Administration of additional new drug or substance into vein, 1 hour or less | 82 | $51 | $178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $26 | $89 |
| Infusion, normal saline solution , 1000 cc | 68 | $2 | $7 |
| Hospital follow-up visit, moderate complexity | 58 | $64 | $197 |
| New patient office visit (45-59 min) | 55 | $126 | $453 |
| Infusion into a vein for hydration, 31-60 minutes | 54 | $26 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 49 | $15 | $56 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 44 | $401 | $680 |
| Red blood count automated, with additional calculations | 42 | $5 | $20 |
| Ct scan of chest with contrast | 39 | $51 | $349 |
| CT scan of abdomen and pelvis with contrast | 37 | $179 | $559 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 35 | $1,167 | $3,706 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 29 | $3 | $11 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 29 | $1 | $7 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $58 | $206 |
| Initial hospital admission, moderate complexity | 22 | $99 | $377 |
| Administration of additional new drug or substance into vein using push technique | 20 | $42 | $170 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $19 | $59 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.3% high complexity
45.4% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,768
Total received (2018-2024)
Avg $2,253/year across 7 years
Top 33% in FL for medical oncology
94
Companies
938
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,642 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,113
2023
$2,946
2022
$2,249
2021
$1,552
2020
$1,423
2019
$1,584
2018
$1,900
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$1,267
PFIZER INC.
$1,126
Novartis Pharmaceuticals Corporation
$1,014
Celgene Corporation
$934
AstraZeneca Pharmaceuticals LP
$713
GENZYME CORPORATION
$599
E.R. Squibb & Sons, L.L.C.
$583
Amgen Inc.
$537
Merck Sharp & Dohme LLC
$513
Seagen Inc.
$470
GlaxoSmithKline, LLC.
$454
Genentech USA, Inc.
$388
Lilly USA, LLC
$360
Bayer HealthCare Pharmaceuticals Inc.
$358
Pharmacyclics LLC, An AbbVie Company
$339
Merck Sharp & Dohme Corporation
$324
Astellas Pharma US Inc
$312
Incyte Corporation
$303
ABBVIE INC.
$287
Alexion Pharmaceuticals, Inc.
$271
Takeda Pharmaceuticals U.S.A., Inc.
$270
Daiichi Sankyo Inc.
$258
BeiGene USA, Inc.
$226
Tempus AI, Inc
$200
Eisai Inc.
$183
Ipsen Biopharmaceuticals, Inc
$164
Dendreon Pharmaceuticals LLC
$155
Kite Pharma, Inc.
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$132
JAZZ PHARMACEUTICALS INC.
$129
Exelixis Inc.
$118
ARRAY BIOPHARMA INC
$110
Deciphera Pharmaceuticals Inc.
$108
SERVIER PHARMACEUTICALS LLC
$95
Pharmacyclics LLC, an AbbVie Company
$94
Bayer Healthcare Pharmaceuticals Inc.
$92
Regeneron Healthcare Solutions, Inc.
$84
EMD Serono, Inc.
$81
TESARO, Inc.
$81
AbbVie Inc.
$77
Seattle Genetics, Inc.
$73
Octapharma USA, Inc.
$73
Adaptive Biotechnologies Corporation
$65
EISAI INC.
$64
TerSera Therapeutics LLC
$64
Shire North American Group Inc
$57
PUMA BIOTECHNOLOGY, INC.
$55
Heron Therapeutics, Inc.
$55
Clovis Oncology, Inc.
$53
Sobi, Inc
$46
Mirati Therapeutics, Inc.
$45
Taiho Oncology, Inc.
$45
Legend Biotech USA Inc.
$45
ADC Therapeutics America, Inc.
$45
Karyopharm Therapeutics Inc.
$45
Agios Pharmaceuticals, Inc.
$45
Jazz Pharmaceuticals Inc.
$42
Genmab U.S., Inc.
$42
TG THERAPEUTICS, INC.
$42
Aveo Pharmaceuticals, Inc.
$40
Array BioPharma Inc.
$39
Aurobindo Pharma USA, Inc.
$38
Pharmacosmos Therapeutics Inc.
$38
Kyowa Kirin, Inc.
$37
AVEO Pharmaceuticals, Inc.
$36
Gilead Sciences, Inc.
$35
Geron Corporation
$31
Puma Biotechnology, Inc.
$30
TAIHO ONCOLOGY, INC.
$29
SpringWorks Therapeutics, Inc.
$28
NanoString Technologies, Inc.
$27
Sirtex Medical Inc
$27
Global Blood Therapeutics, Inc.
$26
Janssen Scientific Affairs, LLC
$25
AbbVie, Inc.
$24
Sun Pharmaceutical Industries Inc.
$22
Alnylam Pharmaceuticals Inc.
$22
Secura Bio, Inc.
$21
Acrotech Biopharma LLC
$20
SOBI, INC
$20
G1 Therapeutics, Inc.
$19
ImmunoGen, Inc.
$19
Blueprint Medicines Corporation
$19
Acrotech Biopharma Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
Verastem, Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
Spectrum Pharmaceuticals Inc.
$15
Emmaus Medical, Inc.
$15
Advanced Accelerator Applications
$15
Dova Pharmaceuticals
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Veracyte, Inc.
$5
NOVARTIS PHARMACEUTICALS CORPORATION
$5
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALOXI · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESPONSA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Endari · Enhertu · Epkinly · FARYDAK · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAMMAGARD · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · PROVENGE · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYTELO · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONVENDI · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · WILATE · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $17 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
21
Per 100K population
1.4
County median income
$81,115
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Santos is a mixed practice specialist, with above-average Medicare volume (top 26% in FL), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Santos experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Santos performed 44,880 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Santos receive payments from pharmaceutical companies?
Yes. Dr. Santos received a total of $15,768 from 94 companies across 938 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santos's costs compare to other medical oncologists in West Palm Beach?
Dr. Santos's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in West Palm Beach
Browse medical oncologists in West Palm Beach ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology